Latest news with #Alpenglow
Business Wire
07-08-2025
- Automotive
- Business Wire
PHINIA Reports Advancements in Strategy, Innovation, and Culture in Second Annual Sustainability Report
AUBURN HILLS, Mich.--(BUSINESS WIRE)-- PHINIA Inc. (NYSE:PHIN), a leader in premium fuel systems, electrical systems, and aftermarket solutions, today released its 2024 Sustainability Report, reflecting company-wide progress across environmental, social, and governance priorities in 2024. Now in its second year, the report details PHINIA's continued investment and development in sustainable operations and innovation, circular economy practices, inclusivity and engagement, employee well-being and development, and responsible supply chain operations, among other key strategies and progress. 'We believe sustainability is not only core to responsible business — it's an important contributor to our long-term success and business strategy. Our sustainability initiatives create lasting value for our stakeholders and fuel innovation driven by our people, our purpose, and our values across engineering, operations, and culture,' said Brady Ericson, President and CEO of PHINIA. 'With this second annual report, we've moved from building a foundation to driving measurable impact. We're continuing to shape a more sustainable future for our industry and communities through data-driven decisions, global collaboration, and targeted investments.' The 2024 Sustainability Report details PHINIA's year-over-year progress and other developments across key environmental, social, and governance initiatives. Highlights from PHINIA's 2024 Sustainability Report include: Investments in More Sustainable Technologies: 89% of PHINIA's 2024 research and development (R&D) investments were dedicated to fuel efficiency and alternative fuel technologies — including for use with zero-carbon fuels and lower-carbon fuels. Hydrogen Innovation in Action: Showcased H 2 ICE developments through partnerships with Alpine Racing for its Alpenglow hydrogen-powered prototype and GCK Group and Solution F with the groundbreaking hydrogen-powered Jeep Cherokee retrofit. Operational Emissions Reductions: Reduced Scope 1 and 2 greenhouse gas (GHG) emissions by 11.7% year-over-year. Established a near-term emissions reduction goal of 50% by 2030 from a 2020 baseline year for absolute Scope 1 and 2 GHG emissions. Smart Energy Management: Reduced energy consumption by 4.5% year-over-year. Implemented a global energy monitoring system across priority manufacturing sites, which represent approximately 85% of PHINIA's total energy consumption — enabling real-time energy efficiency insights and robust trend analysis. Remanufacturing and Circular Economy Innovation: Reused 52% of the core mass of remanufactured material to return functional products back into service at its largest remanufacturing facility in 2024. Over 12 million pounds of material processed for remanufacturing at this facility since 2011. Advanced training initiatives for Design for Environment, PHINIA's process used to quantify and reduce life cycle emissions of new products. Employee Skills-Building and Well-Being: Recorded approximately 145,000 employee training hours, offered mental health first aid training opportunities, launched the global PHINIA Active wellness program, and provided other learning, development, and well-being resources and opportunities. Engaged and Inclusive Culture: Reported global employee engagement survey results, highlighting robust support of PHINIA's culture and trust in our leadership. Introduced global Inclusion strategy, expanded PHINIA Women in Science and Engineering (WISE+) program to 24 chapters across all PHINIA locations, and offered numerous other voluntary engagement opportunities available to all employees. Supply Chain Responsibility and Ethical Business: Recognized 10 suppliers for excellence, including alignment with PHINIA's sustainability expectations, through the PHINIA Partnership Program (3P). 81% of in-scope suppliers (by spend) completed sustainability self-assessments. Expanded ethics and compliance trainings initiatives and resources. PHINIA will continue building on its momentum in 2025, which for environmental-focused initiatives will include the development of a Scope 3 GHG emissions baseline and strategy, broader adoption of renewable energy across global facilities, expansion of life cycle management tools and training, and continued investments in fuel efficiency, alternative fuel systems, and technical training. 'We are proud of our progress — and even more energized by what lies ahead,' said Ericson. 'From more sustainable technologies and establishing emissions reduction goals to engaging our talent and ethical business practices, sustainability continues to guide how we innovate, operate, and grow.' For more information and to view the full 2024 Sustainability Report, please visit To connect with our global sustainability team, please contact sustainability@ About PHINIA PHINIA is an independent, market-leading, premium solutions and components provider, with over 100 years of manufacturing expertise and industry relationships and a strong brand portfolio that includes DELPHI ®, DELCO REMY ® and HARTRIDGE™. With over 12,500 employees across 43 locations in 20 countries, PHINIA is headquartered in Auburn Hills, Michigan, USA. Across commercial vehicles and industrial applications (medium-duty and heavy-duty trucks, buses and other off-highway construction, marine, agricultural and aerospace and defense), light commercial vehicles (vans and trucks) and light passenger vehicles (passenger cars, mini-vans, cross-overs and sport-utility vehicles), we develop fuel systems, electrical systems, and aftermarket solutions designed to keep combustion engines operating at peak performance, while at the same time investing in advanced technologies to unlock the potential of alternative fuels. By providing what the market needs today to become more efficient and sustainable, while also developing innovative products and solutions to contribute to lower carbon mobility, we are the partner of choice for a diverse array of customers – powering our shared journey toward a cleaner tomorrow. © 2025 PHINIA Inc. All Rights Reserved. (DELCO REMY is a registered trademark of General Motors LLC, licensed to PHINIA Technologies Inc.) Forward-Looking Statements: This press release contains forward-looking statements within the meaning of U.S. federal securities laws. Forward-looking statements are statements other than historical facts that provide current expectations or forecasts of future events based on certain assumptions and are not guarantees of future performance. Forward-looking statements use words such as 'anticipate,' 'believe,' 'continue,' 'could,' 'designed,' 'effect,' 'estimate,' 'evaluate,' 'expect,' 'forecast,' 'goal,' 'initiative,' 'intend,' 'likely,' 'may,' 'outlook,' 'plan,' 'potential,' 'predict,' 'project,' 'pursue,' 'seek,' 'should,' 'target,' 'when,' 'will,' 'would,' and other words of similar meaning. Forward-looking statements are subject to risks, uncertainties, and factors relating to our business and operations, all of which are difficult to predict, and which could cause our actual results to differ materially from the expectations expressed in or implied by such forward-looking statements. Risks, uncertainties, and factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: adverse changes in general business and economic conditions, including recessions, adverse market conditions or downturns impacting the vehicle and industrial equipment industries; our ability to deliver new products, services and technologies in response to changing consumer preferences, increased regulation of greenhouse gas emissions, and acceleration of the market for electric vehicles; competitive industry conditions; failure to identify, consummate, effectively integrate or realize the expected benefits from acquisitions or partnerships; pricing pressures from original equipment manufacturers (OEMs); inflation rates and volatility in the costs of commodities used in the production of our products; changes in U.S. and foreign administrative policy, including tariffs, changes to existing trade agreements and import or export licensing requirements, and any resulting changes in international trade relations; our ability to protect our intellectual property; failure of or disruption in our information technology infrastructure, including a disruption related to cybersecurity; our ability to identify, attract, retain and develop a qualified global workforce; difficulties launching new vehicle programs; failure to achieve the anticipated savings and benefits from restructuring and product portfolio optimization actions; extraordinary events, including natural disasters or extreme weather events, fires or similar catastrophic events, political disruptions, terrorist attacks, pandemics or other public health crises, and acts of war; risks related to our international operations; the impact of economic, political, social and market conditions on our business in China; our reliance on a limited number of OEM customers; supply chain disruptions, including due to U.S. and foreign government action; work stoppages, production shutdowns and similar events or conditions; governmental investigations and related proceedings regarding vehicle emissions standards, including the ongoing investigation into diesel defeat devices; current and future environmental, health and safety, human rights and other laws and regulations; the impacts of climate change, regulations related to climate change and various stakeholders' emphasis on climate change and other related matters; compliance with and changes in other laws and regulations; liabilities related to product warranties, litigation and other claims; tax audits and changes in tax laws or tax rates taken by taxing authorities; impairment charges on goodwill and indefinite-lived intangible assets; the impact of changes in interest rates and asset returns on our pension funding obligations; the impact of restrictive covenants and other requirements on our financial and operating flexibility pursuant to the agreements governing our indebtedness; risks relating to the spin-off from our former parent, including our ability to achieve some or all of the benefits that we expect to achieve from the spin-off, a determination that the spin-off does not qualify as tax-free for U.S. federal income tax purposes, and our or our former parent's failure to perform under, or additional disputes that may arise between the parties 4 relating to, various transaction agreements executed in connection with the spin-off; and other risks and uncertainties described in our reports filed from time to time with the Securities and Exchange Commission. We caution readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date they are made. We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Daily Mirror
11-07-2025
- Automotive
- Daily Mirror
Hydrogen-powered hypercar with almost zero emissions debuts in UK
The Alpine Alpenglow concept car was on display at the annual motoring event in West Sussex and is a one-off concept car, but both its hydrogen powertrain and styling are set to inspire future Alpine road cars Petrolheads were treated to the sight of a £3million zero-emission hypercar at the Goodwood Festival of Speed, which roared into action for the first time on UK soil yesterday. Enthusiasts flocked to see the Alpine Alpenglow concept car at the iconic West Sussex motoring celebration. The striking vehicle operates on combusted hydrogen rather than traditional fuels or batteries – its emissions are almost non-existent. Though this Alpenglow model remains unique, it is paving the way for upcoming Alpine cars in both design and eco-friendly powertrain technology. Sporty aesthetics and a hybrid engine of French pedigree that mixes classic petrol with electric firepower are part of Alpine's ambitious plan for a line-up of new models valued north of the £1 million mark. Speaking about Alpine's innovation, Bruno Famin from Alpine Motorsports commented: "With the development of this brand new Hy6 V6 engine, we are demonstrating our commitment to hydrogen research, which could herald motorsport applications with high-performance levels. "The Alpenglow Hy6 concept is the perfect example of what is possible to achieve the essential step of reducing carbon emissions in motorsport." At Goodwood this year, an estimated 200,000 visitors had the opportunity to glimpse the future of racing with the high-octane spectacle of liquid hydrogen engines challenging the dominance of battery electric alternatives. The Alpenglow dazzled crowds when unveiled in 2022, serving as a vision for the trajectory of Alpine's automotive advancements. Building on the success of the first road-going prototype, powered by a 340bhp turbocharged 2.0-litre 4-cylinder engine, the Alpenglow Hy6 now boasts an all-new powertrain that more than doubles its predecessor's output. At its core lies a revolutionary 3.5-litre V6 engine, designed in-house by Alpine to optimise hydrogen combustion. This results in an impressive 544kW (740bhp), equating to over 150kW/l (210bhp/l), and positioning the Alpenglow among the performance elite. The concept's Specular Blue carbon fibre bodywork has been reworked, showcasing more aggressive lines. The spoiler is more pronounced and visible from the front, while the shark-fin has grown in size, proudly displaying the Alpine logo, hydrogen's chemical formula, and an eye-catching magenta to blue gradient that represents its combustion process. Beneath the bonnet, F1-inspired methodologies have been employed to hone the engine's key performance components. Antony Villain, Alpine's VP of Design, noted: "The adaptation of this V6 is a technical challenge, highlighted for all to see in a redesigned rear section. "Various elements of the concept's design are evolving, sculpted by the aerodynamic imperatives implied by its new performance, while visually evoking both speed and the virtuous aspects of hydrogen."
Yahoo
03-06-2025
- Business
- Yahoo
Molecular Instruments and Alpenglow Biosciences Partner to Advance 3D RNA Imaging in Intact Biological Samples
LOS ANGELES & SEATTLE, June 03, 2025--(BUSINESS WIRE)--Molecular Instruments® (MI), the inventor of the innovative HCR™ platform, and Alpenglow Biosciences, a leader in 3D light-sheet microscopy, are excited to announce a partnership that enables high-resolution, three-dimensional RNA imaging in intact biological specimens. By integrating MI's HCR™ Gold RNA-FISH assay with Alpenglow's 3Di™ Hybrid Open-Top Light-Sheet (HOTLS) fluorescent microscope, researchers gain access to a powerful, accessible workflow for visualizing molecular expression patterns in 3D while preserving the native architecture of their samples. This collaboration merges two state-of-the-art technologies into a seamless imaging solution. HCR™ Gold RNA-FISH provides highly specific and sensitive labeling of RNA targets in any sample, including thick tissues and whole-mount specimens. Additionally, the HCR™ platform's small DNA-based amplification reagents enable deep sample penetration and produce strong signals with minimal background, ensuring robust results even in challenging samples. Complementing this, Alpenglow's 3Di™ HOTLS system generates high-resolution 3D reconstructions across a broad range of sample sizes and formats, transforming labeled samples into rich, spatially resolved datasets. Alpenglow further enhances these insights with cutting-edge data processing and AI-driven analysis, enabling a deeper understanding of complex biological systems. "HCR™ products have long enabled researchers to see deeper – delivering gold-standard performance in thick and complex samples, from whole-mount embryos to cleared tissues," said Dr. Aneesh Acharya, Chief Commercial Officer at Molecular Instruments. "We pioneered protease-free sample preparation to preserve fine structure, and now, with Alpenglow, we're entering a new era: democratizing 3D molecular imaging for the translational community. By combining the precision of HCR™ Gold with the power of open-top light-sheet microscopy, we're opening a window into intact biology – making it possible to explore molecular organization in its native context, at scale." "We are excited to work with the team at Molecular Instruments," said Nick Reder, MD and CEO of Alpenglow Biosciences. "With their high-quality HCR™ Gold reagents and ability to penetrate deep tissue, along with our 3Di Instrument, we will bring a powerful new tool to customers seeking to understand the underlying biology of their tissue specimens with labeling of RNA targets. These tools working together will help researchers and drug development scientists to unlock insights within the tissue to help accelerate their scientific programs." Together, the two platforms eliminate the limitations of conventional 2D histology, which often relies on thin tissue sections and can obscure key biological context. This integrated approach empowers researchers to explore intact samples – such as embryos, organoids, and other delicate 3D structures – without disrupting their morphology. In doing so, scientists can uncover spatial patterns and cellular interactions that would otherwise be lost in serial sections. Designed for modern workflows, HCR™ Gold is fully compatible with tissue clearing and automation, ensuring reproducible, scalable performance across large studies. Alpenglow's 3Di™ HOTLS enhances this capability with a versatile imaging system that supports scan volumes up to 12.5 cm by 7 cm and features a 1 cm working distance – delivering high-throughput, adaptive imaging across diverse research applications. This joint solution is especially impactful in fields such as developmental biology, neuroscience, and immunology – areas where understanding molecular organization in 3D is critical to advancing scientific discovery. By combining the precision of HCR™ Gold with the advanced imaging capabilities of 3Di™ HOTLS, MI and Alpenglow Biosciences are offering deeper insights into complex systems and setting a new standard in molecular profiling. About Molecular Instruments Molecular Instruments® ( is a company powering the future of bioimaging through the development of clinical-grade molecular detection technologies. The company offers automated and manual chromogenic and fluorescent in situ hybridization (ISH) assays that seamlessly integrate with existing immunohistochemistry (IHC) and immunofluorescence (IF) workflows. With thousands of users globally, MI is establishing the field standard for RNA detection and supporting applications from academic research to drug development and diagnostics. About Alpenglow Biosciences Alpenglow Biosciences is a 3D spatial biology company focused on accelerating drug development and improving clinical diagnostics with AI-enabled 3D imaging technology. Their platform solution provides new spatial biology insights with greater accuracy by non-destructively digitizing entire tissues. Alpenglow partners with pharmaceutical companies to bring better therapeutics to market faster through greater understanding of mechanism of action, efficacy & toxicology, and clinical trial enrollment using their patented platform. See what you've been missing at View source version on Contacts Media Contact: Joyce YooAssociate Director of Marketingjoyce@ Steve PembertonSVP Commercial Developmentmedia@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
03-06-2025
- Business
- Business Wire
Molecular Instruments and Alpenglow Biosciences Partner to Advance 3D RNA Imaging in Intact Biological Samples
LOS ANGELES & SEATTLE--(BUSINESS WIRE)--Molecular Instruments® (MI), the inventor of the innovative HCR™ platform, and Alpenglow Biosciences, a leader in 3D light-sheet microscopy, are excited to announce a partnership that enables high-resolution, three-dimensional RNA imaging in intact biological specimens. By integrating MI's HCR™ Gold RNA-FISH assay with Alpenglow's 3Di™ Hybrid Open-Top Light-Sheet (HOTLS) fluorescent microscope, researchers gain access to a powerful, accessible workflow for visualizing molecular expression patterns in 3D while preserving the native architecture of their samples. Experience a new era of 3D molecular imaging — HCR™ Gold RNA-FISH meets Alpenglow's 3Di™ light-sheet system to reveal RNA expression in intact tissues with stunning clarity. This collaboration merges two state-of-the-art technologies into a seamless imaging solution. HCR™ Gold RNA-FISH provides highly specific and sensitive labeling of RNA targets in any sample, including thick tissues and whole-mount specimens. Additionally, the HCR™ platform's small DNA-based amplification reagents enable deep sample penetration and produce strong signals with minimal background, ensuring robust results even in challenging samples. Complementing this, Alpenglow's 3Di™ HOTLS system generates high-resolution 3D reconstructions across a broad range of sample sizes and formats, transforming labeled samples into rich, spatially resolved datasets. Alpenglow further enhances these insights with cutting-edge data processing and AI-driven analysis, enabling a deeper understanding of complex biological systems. 'HCR™ products have long enabled researchers to see deeper – delivering gold-standard performance in thick and complex samples, from whole-mount embryos to cleared tissues,' said Dr. Aneesh Acharya, Chief Commercial Officer at Molecular Instruments. 'We pioneered protease-free sample preparation to preserve fine structure, and now, with Alpenglow, we're entering a new era: democratizing 3D molecular imaging for the translational community. By combining the precision of HCR™ Gold with the power of open-top light-sheet microscopy, we're opening a window into intact biology – making it possible to explore molecular organization in its native context, at scale.' 'We are excited to work with the team at Molecular Instruments,' said Nick Reder, MD and CEO of Alpenglow Biosciences. 'With their high-quality HCR™ Gold reagents and ability to penetrate deep tissue, along with our 3Di Instrument, we will bring a powerful new tool to customers seeking to understand the underlying biology of their tissue specimens with labeling of RNA targets. These tools working together will help researchers and drug development scientists to unlock insights within the tissue to help accelerate their scientific programs.' Together, the two platforms eliminate the limitations of conventional 2D histology, which often relies on thin tissue sections and can obscure key biological context. This integrated approach empowers researchers to explore intact samples – such as embryos, organoids, and other delicate 3D structures – without disrupting their morphology. In doing so, scientists can uncover spatial patterns and cellular interactions that would otherwise be lost in serial sections. Designed for modern workflows, HCR™ Gold is fully compatible with tissue clearing and automation, ensuring reproducible, scalable performance across large studies. Alpenglow's 3Di™ HOTLS enhances this capability with a versatile imaging system that supports scan volumes up to 12.5 cm by 7 cm and features a 1 cm working distance – delivering high-throughput, adaptive imaging across diverse research applications. This joint solution is especially impactful in fields such as developmental biology, neuroscience, and immunology – areas where understanding molecular organization in 3D is critical to advancing scientific discovery. By combining the precision of HCR™ Gold with the advanced imaging capabilities of 3Di™ HOTLS, MI and Alpenglow Biosciences are offering deeper insights into complex systems and setting a new standard in molecular profiling. About Molecular Instruments Molecular Instruments® ( is a company powering the future of bioimaging through the development of clinical-grade molecular detection technologies. The company offers automated and manual chromogenic and fluorescent in situ hybridization (ISH) assays that seamlessly integrate with existing immunohistochemistry (IHC) and immunofluorescence (IF) workflows. With thousands of users globally, MI is establishing the field standard for RNA detection and supporting applications from academic research to drug development and diagnostics. About Alpenglow Biosciences Alpenglow Biosciences is a 3D spatial biology company focused on accelerating drug development and improving clinical diagnostics with AI-enabled 3D imaging technology. Their platform solution provides new spatial biology insights with greater accuracy by non-destructively digitizing entire tissues. Alpenglow partners with pharmaceutical companies to bring better therapeutics to market faster through greater understanding of mechanism of action, efficacy & toxicology, and clinical trial enrollment using their patented platform. See what you've been missing at
NZ Autocar
31-05-2025
- Automotive
- NZ Autocar
Will Alpine launch a hydrogen-powered supercar eventually?
Alpine is continuing with development of its hydrogen-powered Alpenglow concept, now evolved into the Hy4 prototype. First revealed in 2022, the Alpenglow's transformation into the Hy4 suggests Alpine is increasingly serious about hydrogen combustion technology. The Hy4, built on a Ligier LMP3 racing chassis, swaps the original single-seat layout for a more conventional two-seat set-up, suggesting a shift towards a road orientation. The Hy4 was set to debut at the World Endurance Championship in Spa-Francorchamps, Belgium. However, an electrical fault prevented that. Alpine's design chief, Antony Villain, is still optimistic. He said that the Alpenglow was always envisioned for both road and track ends. Villain added that Alpine is considering a small production run of the hydrogen-powered supercar. He stressed that both hydrogen-combustion and battery-electric technologies are being pursued at present. Development was always aimed at eventual production, he said, calling the Alpenglow more of a 'programme' than a concept. Future versions will evolve with improved styling and added everyday utility. A critical part of this update is a new V6 hydrogen engine being developed entirely in-house by Alpine. It is set to replace the existing turbocharged 2.0-litre four-cylinder sourced from motorsport partner Oreca. The new V6 should add both power and efficiency. The Hy4's range currently stands at around 100km at race pace. Le Mans racers generally run 10–20 laps of the 14km circuit before refueling so added efficiency is an imperative. Racing vehicles director François Champod stressed the engine will offer accessible, user-friendly power, unlike a high-revving F1 unit. There are still engineering challenges to overcome. Alpine's hydrogen engineer, Pierre-Jean Tardy, explained that while hydrogen combustion produces similar engine response and sound to petrol, it behaves differently. Running lean for efficiency and low NOx emissions leads to cooler exhaust gases, creating challenges for turbochargers, especially increased lag. In addition, hydrogen's wide flammability range complicates combustion control, increasing the risk of engine knock. Mixing hydrogen gas with air uniformly is another major stumbling block, especially at high engine speeds. Hydrogen is injected at very high velocities, making it harder to mix properly and increasing the risk of abnormal combustion. Temperature management within each combustion chamber must also be uniform to avoid reliability issues. Alpine acknowledges that its hydrogen-combustion technology is in its infancy. The V6 has only recently begun testing on a dynamometer. But the goal is to power the Alpenglow with hydrogen by year's end. While Alpine is eyeing entry into the hydrogen-combustion class at the 2027 Le Mans 24 Hours, it has not made a formal commitment yet. A road-going hydrogen car from Alpine remains a long-term possibility. Champod warned that the broader hydrogen infrastructure will determine its future. The current hydrogen refueling network can only support a limited number of vehicles. However, Renault Group's Hyvia venture, focused on hydrogen-powered vans, could aid infrastructure development. Trucks and light commercial vehicles (LCVs) are expected to lead the rollout of hydrogen stations, indirectly supporting niche vehicles like the Alpenglow. Fuel storage on board remains a significant challenge. Hydrogen tanks require more space than petrol equivalents—over 350 litres versus 50 litres—posing packaging problems. Moreover, Alpine insists hydrogen use must be 'clean' to justify its environmental benefits. That means only decarbonized hydrogen (with carbon capture) or green (via renewable-powered electrolysis).
